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The CyclinB1-Cdk1 kinase is the catalytic activity at
the heart of mitosis-promoting factor (MPF), yet
fundamental questions concerning its role in mitosis
remained unresolved. It is not known when and how
rapidly CyclinB1-Cdk1 is activated in mammalian
cells, nor how its activation coordinates the substan-
tial changes in the cell at mitosis. Here, we have
developed a FRET biosensor specific for CyclinB1-
Cdk1 that enables us to assay its activity with very
high temporal precision in living human cells. We
show that CyclinB1-Cdk1 is inactive in G2 phase
and activated at a set time before nuclear envelope
breakdown, thereby initiating the events of prophase.
CyclinB1-Cdk1 levels rise to their maximum extent
over the course of approximately 30 min, and we
demonstrate that different levels of CyclinB1-Cdk1
kinase activity trigger different mitotic events, thus
revealing how the remarkable reorganization of the
cell is coordinated at mitotic entry.INTRODUCTION
Progress through the cell cycle is driven by members of the
Cyclin-dependent kinase (Cdk) family when bound to their Cyclin
partner. There are two types of Cyclin that are important for
mitosis in animal cells: Cyclin A, which also has an important
role in DNA replication, and CyclinB. CyclinB in partnership
with Cdk1 was purified as the catalytic activity in mitosis-
promoting factor (MPF) from Xenopus and starfish eggs that
upon injection drives interphase cells into mitosis (Gautier
et al., 1990; Labbe´ et al., 1989; Lohka et al., 1988). Mammalian
cells have two B-type Cyclins, Cyclins B1 and B2, but only
CyclinB1 is essential in mice (Brandeis et al., 1998): CyclinB2
has a more restricted role in reorganizing the Golgi apparatus
at mitosis (Draviam et al., 2001). As the crucial mitotic inducer,
the activity of CyclinB-Cdk complexes is carefully regulated:
once a B-type Cyclin binds to Cdk1, the complex is inactivated
by the Wee1 kinase family that phosphorylates Cdk1 in the
ATP binding site on a tyrosine residue and, in animal cells, an
adjacent threonine residue (T14 and Y15 in human Cdk1;
Morgan, 2007). Subsequently, the pool of inactive CyclinB-
Cdk1 is activated by the Cdc25 phosphatase family (Cdc25A,DeveB, and C in mammals) and the active kinase phosphorylates
a large number of substrates to reorganize the architecture of
the cell for mitosis (reviewed in Nigg, 1993). Thus, the activation
of CyclinB-Cdk1 is generally considered to trigger entry to
mitosis. This role has been challenged, however, in Drosophila,
where Cyclin A rather than CyclinB is essential (Knoblich and
Lehner, 1993), and by recent siRNA studies in human cells,
which reported that CyclinB1 is not essential for mitotic entry
and that CyclinA2 is required for nuclear envelope breakdown
(NEBD) (Gong et al., 2007; Soni et al., 2008).
Both the Wee1 and Cdc25 families are targets of cell cycle
checkpoints that prevent premature mitosis in the presence of
unreplicated or damaged DNA (Morgan, 2007). Experiments
using Xenopus eggs and mammalian cells indicate that there
are feedback loops between CyclinB-Cdk1 and some of the
Cdc25 isoforms (Izumi and Maller, 1993; Hoffmann et al.,
1993). More recently, elegant experiments using cell-free
extracts from Xenopus eggs showed that Wee1 exhibits ultra-
sensitivity to inactivation by CyclinB-Cdk1 (Kim and Ferrell,
2007), thereby generating bistable states of CyclinB-Cdk1
activity—i.e., either very low or fully active (Pomerening et al.,
2003; Sha et al., 2003; reviewed in Lindqvist, 2009). The temporal
resolution of experiments measuring CyclinB1-Cdk1 kinase
activity until now, however, has been inherently limited because
in vitro kinase assays require populations of cells that are never
perfectly synchronized, and immunofluorescence cannot reveal
the kinetics of activation through time. Mammalian CyclinB1-
Cdk1, therefore, has been reported to be activated at various
times from G2 phase through to prometaphase (Gong et al.,
2007; Jackman et al., 2003; Lindqvist et al., 2007; reviewed in
Lindqvist et al., 2009). Thus, despite its importance to cell divi-
sion, exactly when CyclinB1-Cdk1 is first activated in somatic
cells and the kinetics of its activation are still unknown. To over-
come this limitation, we have developed a FRET-based
biosensor to measure CyclinB1-Cdk1 activity—or rather the
balance between CyclinB1-Cdk1 and an antagonistic phospha-
tase(s)—in individual living mammalian cells as they enter
mitosis. With this probe we reveal that CyclinB1-Cdk1 activation
initiates prophase, and that increasing levels of CyclinB1-Cdk1
activity trigger different mitotic events. Thus, we have begun to
reveal how the remarkable changes in cell architecture at mitotic
entry are coordinated.
RESULTS
We designed a biosensor to detect CyclinB1-Cdk1 kinase
activity in living cells, taking as a template the Fo¨rster resonancelopmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc. 533
Figure 1. FRET Dynamics during Mitotic
Progression
(A) HeLa cells expressing the CyclinB1-Cdk1
activity sensor were recorded at 1 image/104000.
Top: IMD representation of the FRET dynamics
during mitotic progression. Bottom: average curve
of the quantification of the emission ratio over time
in different cells (n = 6). Quantification curves were
aligned on NEBD and were eventually interrupted
in prometaphase (double vertical line) to be
aligned at the onset of anaphase. Note that the
emission ratio is slightly lower in G1 than in G2.
This seems to be due to a differential bleaching
of YFP versus CFP during recording and cell
rounding in some HeLa cells. Note that this decline
is not seen in RPE cells (see Figure 1E).
(B) Average quantification curve of HeLa cells
expressing the inactive CyclinB1-Cdk1 activity
sensor containing the Ser126 to Ala mutation
(n = 5). The slight decrease in the emission ratio
during mitosis is due to cell rounding up and differ-
ential bleaching of YFP versus CFP.
(C) Quantification of the emission ratio for the
whole cell, the nucleus or the cytoplasm only in
a HeLa cell progressing from G2 to mitosis.
(D) Dynamics of FRET signal during reentry to
mitosis. HeLa cells coexpressing the CyclinB1-
Cdk1 activity sensor and a nondegradable Cyclin-
B1L42A/R45A-mCherry were arrested in metaphase
and forced to exit mitosis by adding 300 nM Cdk
inhibitor III (t = 0). After 27 min the drug was
extensively washed out. The top cell reenters
mitosis whereas the bottom cell does not. The
quantification curves of the two cells are dis-
played. Note that in this figure the FRET level in
prometaphase was set at 100%.
(E) Average curve of the quantification of the
emission ratio during mitosis in RPE cells (n = 5)
expressing the CyclinB1-Cdk1 activity sensor.
Curves were aligned on NEBD and the onset of
anaphase as in (A).
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et al., 2001), where the donor and acceptor fluorescent proteins
are linked by a phosphorylation site specific for the kinase and
a phosphobinding domain (see Figure S1A available online).
When this linker site is phosphorylated it is bound by the phos-
phobinding domain, thereby inducing a conformational change
that alters the FRET efficiency between the donor and acceptor
proteins that can be quantified by calculating the ratio of donor to
acceptor emission fluorescence intensities (see Experimental
Procedures). As the FRET pair we used mCerulean (Rizzo
et al., 2004) and YPet (Nguyen and Daugherty, 2005) fluorescent
proteins, and as the phosphobinding domain we used the polo
box domain (PBD) of Plk1 that binds to CDK phosphorylation
sites in vivo (Elia et al., 2003). The key to any protein kinase
biosensor is the specificity of the phosphorylation site and we
required a site that would be phosphorylated by CyclinB1-
Cdk1, but not by any other Cyclin-Cdk or related kinase. There-534 Developmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Ifore, we used 16 amino acids encompassing the autophosphor-
ylation site from human CyclinB1 (Hagting et al., 1999). This
site is only phosphorylated when CyclinB1-Cdk1 is activated
(Borgne et al., 1999; Jackman et al., 2003), indicating that it is
not recognized by other Cyclin-Cdks in the cell. We changed
the residue at position 1 to a serine to optimize binding
between the autophosphorylation site and the PBD, a position
that has minimal effects on recognition by Cyclin-Cdks (Holmes
and Solomon, 1996).
The Biosensor Specifically Measures CyclinB1-Cdk1
Activity
We expressed our biosensor in HeLa cells and observed that the
emission ratio changed only as cells performed mitosis (Fig-
ure 1A; Movie S1). This change in the emission ratio was caused
by an increase in the FRET efficiency because photobleaching
the acceptor caused an almost two-fold higher increase in thenc.
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G1 or G2 phase (Figure S1C).
Extensive experiments demonstrated that the change in FRET
efficiency of the sensor specifically responded to CyclinB1-Cdk1
kinase activity. First of all the change in FRET during mitosis
required phosphorylation of the linker site because there was
no change in FRET efficiency when alanine was substituted at
this position (Figure 1B; Movie S2; n = 25, three independent
experiments), and we confirmed that the phosphorylation was
mitosis-specific using an antibody that specifically recognized
phosphorylation on the autophosphorylation site of CyclinB1
(Figure S1B). Crucially, the sensor was not phosphorylated by
other Cyclin-Cdk complexes in vivo, which we demonstrated in
several ways. We coexpressed a DsRed1-DNA ligase I fusion
protein to identify cells in S phase by their replication foci (Eas-
waran et al., 2004) and found that there was no change in the
FRET efficiency in G1 phase (when CyclinB1 is absent) or early
S phase (when CyclinE-Cdk2 is most active) (Figure S2A and
Movie S3 for HeLa cells; Figure S2B for RPE cells). FRET
efficiency was also constant during G2 phase where CyclinA2-
Cdk2 and CyclinA2-Cdk1 activities progressively increase
(Figure 1C; Koop, 2007; Pines and Hunter, 1990). Furthermore,
there was no difference in the FRET signal between the nucleus
and the cytoplasm in G2 phase, whereas CyclinA2 is predomi-
nantly nuclear (Figure 1C). Moreover, adding either of two Cdk
inhibitors (Cdk1/2 inhibitor III or RO3306) did not affect the
FRET signal in G1, S, or G2 phases, but immediately reversed
it in prometaphase or metaphase cells (Figures S3A and S3B).
Inhibitors of other kinases (Aurora B, Plk1, and MAP kinases)
had no direct effect on the FRET signal (Figure S3B and data
not shown).
Further proof that CyclinA2-Cdk activity did not contribute to
the FRET signal was that the signal continued to increase in
prometaphase after NEBD when CyclinA2, but not CyclinB1, is
degraded (den Elzen and Pines, 2001; Geley et al., 2001; Figures
1A, 1C, and 1E). To confirm this we blocked cells in prometa-
phase with nocodazole and monitored CyclinA2 degradation
using a CyclinA2-mCherry fusion protein. This showed that the
FRET signal remained unchanged while CyclinA2 was degraded
(Figure S4A; n = 5/5). Moreover, the FRET signal immediately
decreased upon the addition of a Cdk inhibitor (Cdk1/2 inhibitor
III; Figure S4A) indicating that the biosensor was phosphorylated
by another mitotic Cyclin-Cdk, almost certainly CyclinB1-Cdk1.
Our biosensor appeared to be primarily responsive to CyclinB1-
Cdk1 because the FRET profile was identical in wild-type mouse
embryo fibroblasts (MEFs) and in MEFs lacking CyclinB2 (kind
gift of Dr. Tim Hunt) (Figure S4B). Finally, the sensor faithfully
responded to changes in CyclinB1-Cdk1 activity level. Express-
ing a nondegradable version of CyclinB1 (R42A/L45A) arrested
cells in mitosis and the FRET signal remained high, but it
dropped as soon as we added a Cdk inhibitor (Figure 1D). These
cells then exited mitosis and degraded the endogenous B-type
Cyclins (Potapova et al., 2006; and data not shown). Washing
out the inhibitor caused a proportion of the cells to re-enter
mitosis driven specifically by the reactivation of the non-degrad-
able CyclinB1-Cdk1, now the only mitotic Cyclin-Cdk in the cell
(Potapova et al., 2006), and in these cells the FRET signal
increased to its original level before addition of the inhibitor
(Figure 1D; Movie S4; n = 5/5).DeveThus, we conclude that our biosensor specifically assays
CyclinB1-Cdk1 activity during the cell cycle, although the final
readout is clearly the balance between CyclinB1-Cdk1 activity
and that of the antagonistic phosphatase(s) that recognizes the
biosensor (see Discussion), which, in effect, is the biological
activity of Cyclin B1-Cdk1.
CyclinB1-Cdk1 Is Initially Activated in Prophase
With a CyclinB1-Cdk1 specific sensor we were in a position to
measure exactly when, and with what kinetics, CyclinB1-Cdk1
was activated during the cell cycle. We found that CyclinB1-
Cdk1 was inactive during G2 phase (Figures S2 and S3), and
only began to be activated at the start of prophase (Figure 1A;
n = 50, six independent experiments; Movie S1). CyclinB1-
Cdk1 was initially activated in HeLa cells 27 ± 7 min before
NEBD (Figure 1A). After its initial activation, CyclinB1-Cdk1
activity increased progressively in prophase and continued to
increase for 10 min after NEBD. We confirmed these results
using hTert-RPE cells where CyclinB1-Cdk1 activity first
increased 18 ± 6 min before NEBD and continued to increase
for 6.5 min in prometaphase (Figure 1E; n = 18, two indepen-
dent experiments). The maximum extent of the FRET change
was independent of the expression level of the biosensor, indi-
cating that the biosensor did not become a limiting substrate
during mitosis (Figure S5). Equally, the biosensor had no effect
at any expression level on the timing of events at mitotic entry
such as centrosome maturation or the accumulation of CyclinB1
in the nucleus that we have found is an excellent marker for the
activation of CyclinB1-Cdk1 (Figure S6A) (Gavet and Pines,
2010). At high expression levels the biosensor delayed cells in
prometaphase, probably because its PBD competed with
endogenous Plk1 and activated the spindle assembly check-
point (SAC) (Figure S6B; Seong et al., 2002).
Plk1 Is Not Required for the Amplification
of Human CyclinB1-Cdk1 Activity
Our ability to measure the kinetics with which CyclinB1-Cdk1
was activated in living cells allowed us to begin to determine
the roles of the protein kinases and phosphatases that have
been implicated in the control of its activity.
We first investigated the role of Polo-like kinase 1 (Plk1)
because Plx1 (its Xenopus homolog) had been reported to
form an amplification loop with Cdc25 essential for CyclinB1-
Cdk1 activation (Abrieu et al., 1998). We compared precisely
the kinetics of CyclinB1-Cdk1 activation in the presence and
absence of Plk1 activity by recording the FRET signal before
and after adding a potent Plk1 inhibitor (BI 2536) (Le´na´rt et al.,
2007) (Figure 2A). As expected, all cells entering mitosis in the
presence of the Plk1 inhibitor blocked in prometaphase due to
activation of the SAC (Le´na´rt et al., 2007), demonstrating that
the inhibitor was effective. In both cell types, inhibiting Plk1
induced an immediate and strong delay in mitotic entry in most
cells that lasted for a few hours (Figure 2B, Movie S5, and data
not shown), but once the cells initiated the activation of
CyclinB1-Cdk1 they entered mitosis with normal kinetics (Fig-
ure 2A): there was no difference in either the kinetics or the extent
of change in FRET efficiency in the presence or absence of the
inhibitor (Figure 2A). Thus, in human cells, Plk1 does not appear
to act in an amplification loop with human CyclinB1-Cdk1,lopmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc. 535
Figure 2. Plk1 Activity Is Required for
Mitotic Entry but Not for CyclinB1-Cdk1
Activation Per Se
(A) The FRET signal was recorded (1 image/2 min)
during mitotic entry in HeLa cells expressing the
CyclinB1-Cdk1 activity sensor before (left panel)
and after (right panel) addition of Plk1 inhibitor
BI2536 (100 nM) to the same dish. Average curve
of three cells is displayed for each condition.
(B) RPE cells were synchronized in G2 phase by
release from serum starvation and recorded at
1 image/2 min by DIC microscopy. The peak of
mitotic entry is indicated by vertical dashed lines
(27–32 hr after serum readdition). The addition
of the Plk1 inhibitor BI2536 100 nM rapidly induces
a strong delay in mitotic entry.
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activation.
CyclinB1-Cdk1-Dependent Phosphorylation Begins
to Be Reversed at Anaphase
Once the FRET signal reached a maximum a few minutes after
NEBD it remained almost constant throughout prometaphase
and metaphase before dropping sharply at the beginning of
anaphase (average 3.5 min or 1 min before visible sister chro-
matid separation in HeLa, n = 12, and RPE, n = 11, cells, respec-
tively; Figures 1E and 3A). The same result was observed in
MEFs with or without CyclinB2 (Fig.S4B). Although the FRET
signal remained constant throughout metaphase, the amount
of kinase activity should have decreased because CyclinB1
started to be degraded from the beginning of metaphase (Clute
and Pines, 1999; Figure 3A). We reasoned that because the
FRET signal represented the balance between CyclinB1-Cdk1
activity and an opposing phosphatase(s), the unchanging FRET
signal in metaphase indicated that the phosphatase(s) was rate
limiting in metaphase but not anaphase. In support of this,
whereas adding a Cdk inhibitor in prophase, prometaphase, or
metaphase (Figures S3A and S3B) caused an immediate
decrease in the FRET efficiency, adding the inhibitor in early
anaphase had no effect on the rate of the FRET decrease,
even in cells with measurable residual CyclinB1 (n = 6/6;
Figure 3B and data not shown). This indicated that in anaphase
the biosensor was primarily responsive to the antagonistic phos-
phatase(s). Unfortunately, we were unable to identify this phos-
phatase(s) despite using several different chemical inhibitors
because most proved highly toxic. High concentrations (1 or
10 mM) of okadaic acid and most concentrations of calyculin A,536 Developmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc.a potent PP2A and PP1 inhibitor, almost
immediately killed the cells. Neverthe-
less, adding 100 nM okadaic acid to
inhibit primarily PP2A before or during
anaphase had no effect on the FRET
behavior, allowing us to conclude that
PP2A is unlikely to dephosphorylate the
biosensor. The sudden decrease in
FRET efficiency at anaphase did not
depend on the activation of separase
because the FRET signal still droppedin cells expressing a nondegradable securin mutant (n = 5/5)
(Hagting et al., 2002; Figure S7).
The persistent high FRET ratio in the presence of declining
levels of CyclinB1-Cdk1 followed by a steep decline at mitotic
exit was also observed in cells undergoing ‘‘mitotic slippage’’
in the presence of nocodazole (Figure 3C). Previous studies
showed that CyclinB1 levels gradually declined in cells arrested
in mitosis with a microtubule poison until the cells eventually
exited mitosis (Brito and Rieder, 2006). Our biosensor revealed
that in RPE cells blocked in nocodazole, the FRET efficiency
remained unchanged for up to 13 hr (n = 5/5; Figure 3C; Movie
S6) while CyclinB1 was progressively degraded (Brito and
Rieder, 2006). Eventually, the FRET signal precipitously
decreased over 20 min (as at a normal anaphase) and this
correlated with visible signs of mitotic exit (Figure 3C; Movie
S6). We conclude that CyclinB1-Cdk1 activity must drop below
a threshold before the cells exit mitosis, but once below this
threshold dephosphorylation of CyclinB1-Cdk1 substrates is
rapid (see Discussion).
Initial Events Regulated by CyclinB1-Cdk1 Activation
The biosensor enabled us to determine which cellular events are
initiated when CyclinB1-Cdk1 is first activated. The event most
closely correlated with the initial activation of CyclinB1-Cdk1
was that cells began to round up. We measured the cell surface
in contact with the dish using DIC or fluorescence images and
found an excellent correlation between when the FRET signal
began to increase and the cell surface began to decrease in
both HeLa (n = 10) and RPE cells (n = 5) (Figures 4A and 4B;
Movie S7). Cell rounding in prophase depended on CyclinB1-
Cdk1 activity because adding a Cdk inhibitor during prophase
Figure 3. FRET Dynamics during Normal Mitotic Exit and Mitotic
Slippage
(A) HeLa cells coexpressing the CyclinB1-Cdk1 biosensor and CyclinB1-
mCherry were recorded during mitotic progression (1 image/104000). The
FRET signal and the decrease of CyclinB1-mCherry fluorescence intensity
(a measure of its proteolysis) during mitotic exit are displayed.
(B) HeLa cells expressing the CyclinB1-Cdk1 activity sensor were recorded at
1 image/min until the beginning of anaphase at which point Cdk 1/2 inhibitor III
(300 nM) was added and images taken at 1 image/10 s. Note that there is no
change in the rate of FRET decrease after adding the Cdk inhibitor in anaphase
(n = 6/6).
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Deveimmediately and completely reversed both the FRET signal
increase and cell rounding (Figure 4C; n = 5/5). Moreover, it
was possible to reverse cell rounding until very late in prophase
when the cell surface had decreased to its maximum extent
(80%; Figure 4C, cell A; Movie S8). Neither a Plk1 inhibitor
(BI2536) nor an Aurora B inhibitor, ZM447439 (Ditchfield et al.,
2003) reversed cell rounding (Gavet and Pines, 2010). Thus,
some of the earliest substrates of CyclinB1-Cdk1 are those
required to reorganize the cytoskeleton to enable the cell to
round up.
Centrosome separation is often taken as a surrogate marker
for mitotic entry and for the activation of CyclinB1-Cdk1,
because the Eg5 kinesin that drives centrosomes apart is phos-
phorylated in vitro by CyclinB1-Cdk1 to increase binding to
microtubules (Blangy et al., 1995; Sawin and Mitchison, 1995).
To assay this correlation in vivo, we coexpressed the biosensor
with mCherry-tagged a-tubulin. In asynchronous HeLa cells,
centrosomes began to migrate away from each other on average
2.5 min after the FRET signal began to increase (n = 14) (Fig-
ure 5A; Movie S9), and a similar correlation was seen in RPE cells
synchronized by release from serum starvation (on average t = 0,
n = 7; Figure 5B). Surprisingly, in HeLa cells synchronized by a
thymidine block and release regime, centrosomes often prema-
turely separated, with a broad variability in timing ranging from
0 to at least 90 min (average 35 min) before the FRET signal
began to increase (Figure 5E; n > 36). Thus, centrosome separa-
tion only correlated with CyclinB1-Cdk1 activation in an unper-
turbed cell cycle.
Different Thresholds of CyclinB1-Cdk1 Activity Trigger
Specific Events in Prophase
The other event that consistently followed the activation of
CyclinB1-Cdk1 was that CyclinB1 began to move into the nucleus
(Pines and Hunter, 1991), and further experiments revealed that
the active CyclinB1-Cdk1 kinase strongly stimulated its own
nuclear import (Gavet and Pines, 2010). Soon after CyclinB1-
Cdk1 began to move into the nucleus, we noticed progressive
changes in nuclear structure, including visible chromosome
condensation—as assayed by DIC or Histone H2B-GFP
imaging—disassembly of the nucleolus, and lastly, NEBD. This
raised the possibility that different thresholds of CyclinB1-Cdk1
activity might be required to trigger different events.
Another crucial nuclear substrate for CyclinB-Cdk1 is the
anaphase-promoting complex/cyclosome (APC/C), whose
phosphorylation by CyclinB1-Cdk1 promotes the subsequent
degradation of CyclinB1 (Kraft et al., 2003; Rudner and Murray,
2000). Pomerening and coworkers recently showed that a
Cdk1 mutant that cannot be inactivated by the Wee1 kinase
family (Cdk1AF) caused cells to perform several rapid cycles of
CyclinB1 accumulation and destruction without chromosome
segregation or cytokinesis (Pomerening et al., 2008). We hypoth-
esized that a lower threshold of CyclinB1-Cdk1 might be(C) RPE cells expressing the CyclinB1-Cdk1 biosensor were synchronized in
G0 by serum starvation and 24 hr after release, 200 nM nocodazole was
added. The FRET signal was recorded 4 hr after addition of nocodazole at
1 image/4 min. Quantification of the emission ratio and the cell surface area
at mitotic exit in one typical cell is displayed. Note that the emission ratio is
stable during 13.2 hr and rapidly decreases during mitotic exit (n = 5/5).
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Figure 4. Cell Rounding in Prophase Is
Concurrent with Initial Activation of Cy-
clinB1-Cdk1
(A) Asynchronous HeLa cells expressing the Cy-
clinB1-Cdk1 biosensor were recorded (1 image/2
min) and the FRET signal and surface area
measured. Quantifications of the emission ratio
and cell surface of three cells entering mitosis
are displayed.
(B) RPE cell expressing the CyclinB1-Cdk1 sensor
was followed by time-lapse fluorescence micros-
copy at 1 image/1015 min. The quantification
curves of the cell are displayed.
(C) Cell rounding up in prophase is reversed by
a Cdk inhibitor. The changes in cell surface and
FRET efficiency were measured on synchronized
HeLa cells recorded at 1 image/2 min as they
entered prophase, then every minute after addition
of Cdk1/2 inhibitor III (300 nM). The star indicates
the cell displayed.
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we first coexpressed the biosensor in cells with Cdk1AF-mCherry
to measure CyclinB1-Cdk1 activity and found that low levels of
CyclinB1-Cdk1 activity, visualized by a weak increase in FRET
activity (<10%), could trigger cell rounding but were insufficient
to trigger NEBD (n = 5) (Figure 6, cells A and C, two first M
phase-like states); both nucleolar disassembly and NEBD
required higher levels of kinase activity (n = 6) (Figure 6, cells B
and C, third M phase-like state). To measure the amount of Cy-
clinB1 protein in the nucleus and assay APC/C activity, we coex-
pressed the biosensor with a CyclinB1-Cdk1AF-mCherry fusion
protein (Katsuno et al., 2009). In all cells analyzed (n = 19), low
levels of CyclinB1-Cdk1 activity, visualized by low FRET
increases (<10%), could trigger CyclinB1-Cdk1 import into the
nucleus and subsequently CyclinB1 degradation and mitotic538 Developmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc.exit, but not NEBD (n = 10) (Figure 7).
NEBD and subsequently chromosome
alignment and cytokinesis were only
triggered in those cells with higher levels
of CyclinB1-Cdk1 activity (FRET increase
around 15%; Figures 6B and 6C and data
not shown).
Altogether, our results show that the
initial low levels of CyclinB1-cdk1 activity
are sufficient to trigger cell rounding, im-
port into the nucleus, and subsequently
activate the APC/C, but higher activity is
required to trigger disassembly of the
nucleolus and NEBD. Thus, the progres-
sive increase in levels of CyclinB1-Cdk1
activity coordinates the reorganization of
the cell in prophase.
DISCUSSION
Our results provide a much clearer idea for
how cells coordinate cellular changes at
entry to mitosis. The initial activationof CyclinB1-Cdk1 takes place about 20 to 25 min before NEBD,
depending on the cell type. The time between activation of
CyclinB1-Cdk1 and NEBD appears to be remarkably constant
between cellsof a particular cell type, and the kineticsof activation
indicates that it is progressively activated over a period of approx-
imately 30 min. Initially, there is only a small increase in CyclinB1-
Cdk1 activity that should be reversible because we and others
have shown that the antephase checkpoint prevents cells
completing prophase if it is activated before the nucleolus breaks
down (Matsusaka and Pines, 2004; Rieder and Cole, 1998). All the
events classically used to define prophase, including centrosome
separation, cell rounding and chromosome condensation, are
initiated only after CyclinB1-Cdk1 activity begins to rise. Thus,
we propose that the rise in CyclinB1-Cdk1 activity can be used
as a molecular definition of prophase (Pines and Rieder, 2001).
Figure 5. Centrosome Separation Is Not
a Consistent Marker for CyclinB1 Activation
(A and C) Asynchronous HeLa cells coexpressing
the CyclinB1-Cdk1 biosensor and mCherry-a-
tubulin were followed by time lapse fluorescence
microscopy at 1 image/2 min. The FRET quantifi-
cation curves of three different cells are displayed
and the beginning of centrosome migration for
each cell is indicated by a vertical dashed line (C).
(B and D) Synchronized RPE cells coexpressing
the CyclinB1-Cdk1 sensor and mCherry-a-tubulin
were followed by time lapse fluorescence micros-
copy at 1 image/2 min. The FRET quantification
curves of three different cells are displayed. The
beginning of centrosome migration for each cell
is indicated by a vertical dashed line (D).
(E) HeLa cells coexpressing the CyclinB1-Cdk1
biosensor and mCherry- a-tubulin were synchro-
nized in S phase by a thymidine block and release
regime and assayed by time-lapse fluorescence
and DIC microscopy. Upper panel: In the cell dis-
played the centrosomes separated >50 min before
NEBD. Bottom panel: time between beginning of
FRET increase and centrosome separation in
typical experiments using asynchronous (n = 14)
or synchronized (n = 12) HeLa cells. Note that
centrosome separation begins at random during
G2 phase in synchronized HeLa cells.
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agrees well with the activation kinetics (30 min) of CyclinB-
Cdk1 measured in Xenopus egg extracts (Kim and Ferrell,
2007). The progressive activation of CyclinB1-Cdk1 might be
surprising considering that the phosphorylation and inactivation
of Wee1 by CyclinB1-Cdk1 exhibits ultrasensitivity, i.e.,
CyclinB1-Cdk1 kinase activity has to reach a threshold before
it inactivates Wee1 (Kim and Ferrell, 2007). One explanation for
the extended activation period might be that during this time
the feedback loops between CyclinB1-Cdk1 and its regulators
could be counterbalanced by phosphatase activities. Germane
to this might be the recent proposal that the Greatwall kinase
participates in the feedback loops by downregulating phospha-
tase activities (Vigneron et al., 2009; Zhao et al., 2008), but
at present the kinetics with which Greatwall is activated is
unknown. In Xenopus extracts, phosphatase activities are inac-Developmental Cell 18, 533–5tivated during mitotic entry as a direct
consequence of CyclinB1-Cdk1 activa-
tion (Mochida and Hunt, 2007; Wu et al.,
2009). If these phosphatases act on the
CyclinB1-Cdk1 biosensor this will not
affect our determination of cellular events
associated with the initial activation of the
kinase but could modify the rate of the
FRET increase later in mitosis.
One difference between our findings
and those using Xenopus extracts (Abrieu
et al., 1998) is that Plk1 does not appear
to be part of the CyclinB1-Cdk1 amplifi-
cation loop in mammalian cells, since
inhibiting Plk1 does not influence thekinetics with which CyclinB1-Cdk1 is activated. Instead, we
find that Plk1 has an important role upstream of CyclinB1-
Cdk1 because in the presence of a Plk1 inhibitor, BI2536, cells
delay considerably in G2 phase. A previous study using BI2536
also found a profound delay in mitotic entry but concluded that
this was in prophase (Le´na´rt et al., 2007). We, however, could
not detect any sign of prophase, such as chromosome conden-
sation, before CyclinB1-Cdk1 activation in HeLa or RPE cells in
the presence of the Plk1 inhibitor. Moreover, in agreement with
our results, Le´ne´rt and colleagues also found that in cells treated
with BI2536, CyclinB1-Cdk1 is imported into the nucleus with
normal timing before NEBD.
The role of Plk1 upstream of CyclinB1-Cdk1 is not yet clear.
Plk1 regulates the activity of the FoxM1 transcription factor to
transcribe genes encoding important mitotic regulators, which
would, therefore, accumulate more slowly in cells treated with43, April 20, 2010 ª2010 Elsevier Inc. 539
Figure 6. NEBD Requires High Levels of
CyclinB1-Cdk1 Activity
HeLa cells coexpressing the CyclinB1-Cdk1
biosensor and Cdk1AF-mCherry. Three cells
entering M phase-like states without cytokinesis
are displayed. Low CyclinB1-Cdk1 activity, visual-
ized by a weak increase in FRET activity, is suffi-
cient to trigger cell rounding up (cell A and the
two first M phase-like states of cell C), but higher
levels are required for NEBD (cell B) and third M
phase-like state of cell C.
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CyclinB1-Cdk1 Coordinates Entry to Mitosisthe BI2536 inhibitor (Fu et al., 2008). Alternatively, Plk1 might
facilitate the activation of a ‘‘trigger’’ Cdc25 phosphatase to
initiate the activation of the CyclinB1-Cdk1 pool (Lobjois et al.,
2009) or downregulate inhibitors of CyclinB1-Cdk1 such as
Wee1 (Watanabe et al., 1995).
The increase in CyclinB1-Cdk1 activity that we are now able to
measure in mammalian cells differs from that previously sug-
gested by a study using immunofluorescence to quantify the
change in phosphorylation on tyrosine 15 of Cdk1, which con-
cluded that CyclinB1-Cdk1 was partially activated in G2 phase.
That assay, however, could not reveal the kinetics with which
CyclinB1-Cdk1 is activated in an individual cell since it required
fixed cells (Lindqvist et al., 2007), and our own results using an
antibody recognizing the autophosphorylated form of Cyclin B1540 Developmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc.as a marker for the active kinase agrees
with the prophase activation we show
here (Jackman et al., 2003). Nevertheless,
our study does agree with Lindqvist and
colleagues’ conclusion that CyclinB1-
Cdk1 activity progressively increases and
continues after NEBD.
We have also shown that centrosome
separation should not be used as a surro-
gate marker for CyclinB1-Cdk1 activa-
tion. In cells synchronized by release
from an S phase block centrosomes
often separated more than an hour before
CyclinB1 itself was activated. This could
be because cells synchronized in S phase
accumulate higher than normal levels of
CyclinA (Koop, 2007) and overexpression
of CyclinA-Cdk2 has previously been
shown to trigger centrosome splitting
(Meraldi and Nigg, 2001). In contrast, we
found that the import of CyclinB1 into
the nucleus consistently matched the
activation of CyclinB1-Cdk1 assayed by
the FRET sensor. In light of these find-
ings, we would like to suggest that the
observations of Gong et al. (2007) also
support the role of CyclinB1 in triggering
NEBD. Gong et al. used centrosome
separation as their marker for CyclinB1-
Cdk1 activity and found that NEBD was
delayed in cells depleted of CyclinA2,
hence concluding that CyclinA2 wasrequired for NEBD. Yet in these cells, CyclinB1 moved into the
nucleus at the correct time before NEBD, and from this we would
conclude that CyclinB1-Cdk1 activation was delayed in cells
depleted of CyclinA but still eventually triggered NEBD. Indeed,
this would agree with our own observations on the effects of
depleting CyclinA in somatic cells (Koop, 2007; F.J. Walton
and J.P., unpublished data).
Using our biosensor, we can for the first time correlate events
triggered by the initial activation of the kinase, and thus likely to
involve high affinity substrates, with those that occur only after
CyclinB1-Cdk1 has reached particular levels, and are thus likely
to involve lower affinity substrates (or substrates bound to antag-
onistic phosphatases). Since CyclinB1-Cdk1 activation immedi-
ately causes cells to begin to round up this adds weight to the
Figure 7. CyclinB1 Degradation Is Triggered by Low Levels of
CyclinB1-Cdk1 Activity and Is Independent of NEBD
HeLa cells coexpressing the CyclinB1-Cdk1 biosensor and a CyclinB1-
Cdk1AF-mCherry fusion protein. Three cells entering M phase-like states
without cytokinesis are displayed. Low CyclinB1-Cdk1 activity, visualized by
a weak increase in FRET activity, is sufficient to trigger nuclear import of
CyclinB1-Cdk1AF and its subsequent degradation in the absence of NEDB.
The onset of CyclinB1-Cdk1AF degradation is indicated on the pseudocolor
(rainbow LUT) images. For each cell, the quantification of the FRET activity,
the level of CyclinB1-Cdk1AF-mCherry and its nuclear accumulation are shown.
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Deveevidence that CyclinB1-Cdk1 is first activated in the cytoplasm
(Jackman et al., 2003; Lindqvist et al., 2007). Moreover, a propor-
tion of active CyclinB1-Cdk1 kinase immediately begins to move
into the nucleus, due to a change in the nuclear transport
machinery (Gavet and Pines, 2010), after which the chromo-
somes condense, the APC/C is activated, the nucleolus disap-
pears, and finally the nuclear envelope breaks down. Our exper-
iments have revealed that both nucleolar disassembly and NEBD
require a higher threshold of Cdk activity than does cell rounding
or the activation of the APC/C. Thus, the increasing level of
CyclinB1-Cdk1 activity coordinates events during prophase.
Our observations also constitute (to our knowledge) the first
direct demonstration that cell cycle events can be coordinated
by changing thresholds of a single Cyclin-Cdk, as first proposed
by Stern and Nurse (1996) for the fission yeast cell cycle.
CyclinB1-Cdk1 activity reaches its maximum shortly after
NEBD and this maintains the cell in its mitotic state until
CyclinB1-Cdk1 substrates begin to be dephosphorylated in
anaphase, after CyclinB1-Cdk1 itself has begun to be inacti-
vated by the destruction of CyclinB1. The rapid and abrupt
inactivation of our biosensor may indicate that this dephosphor-
ylation is only effective when CyclinB1 has dropped below a
threshold or that there is a positive signal that triggers anaphase.
If there is a positive signal it does not require active separase,
unlike the mitotic exit network in budding yeast (D’Amours and
Amon, 2004). Instead, we suspect that the rapid decrease in
the FRET signal at anaphase is likely to reflect the activation of
a phosphatase(s). Our okadaic acid results tend to exclude a
role for PP2A and genetically the PP1 family of phosphatases
has been most clearly shown to be required for mitotic exit
(Ohkura et al., 1989). Moreover, PP1 is repressed in part by
phosphorylation by CyclinB1-Cdk1 from early mitosis until
anaphase (Kwon et al., 1997; Wu et al., 2009; Yamano et al.,
1994), and Wu and coworkers recently showed that PP1 autoac-
tivates by dephosphorylating its Cdk-dependent phosphoryla-
tion once Cdk1 levels have dropped (Wu et al., 2009).
Our newfound ability to measure CyclinB1-Cdk1-specific
phosphorylation should help us to dissect how the remarkable
reorganization of the cell as it enters and exits mitosis is achieved.
EXPERIMENTAL PROCEDURES
Cell Culture and Synchronization
HeLa cells were cultured in Advanced DMEM (Invitrogen) supplemented
with 2% FBS (Invitrogen), Glutamax-1 (200 mM), Penicillin (100U/ml), Strepto-
mycin (100 mg/ml), and Fungizone (250 ng/ml) at 37C, 10% CO2. MEF and
hTert-RPE1 cells (BD Biosciences) were cultured in 50:50 DMEM Nutrient
Mixture + Ham’s F-12 (Sigma-Aldrich) supplemented with 10% FBS, Gluta-
max-1, Penicillin, Streptomycin, and Fungizone at 37C, 5% CO2. Medium
for hTert-RPE cells was supplemented with 0.25% sodium bicarbonate. For
time lapse imaging, cells were cultured on glass bottom dishes (Willco Wells)
precoated with fibronectin (Sigma-Aldrich) at 1 mg/cm2 for 2 hr before using.
HeLa cells were synchronized in S phase with 2.5 mM thymidine for 24 hr
then released into fresh medium. hTert-RPE cells were synchronized by serum
starvation for 24 hr (DMEM:F-12 supplemented with 0.1% serum) then
released into the same medium with 10% FBS. MEFs were not synchronized.
Transfection
HeLa cells were electroporated (3 3 106 cells, 10 to 20 mg of DNA) at 250 V,
1500 mF in 4 mm cuvettes with an Easyject plus electroporator (Equibio). Cells
were immediately plated on coated glass-bottom dishes and synchronized
by a thymidine block and release regime 7 hr after transfection. Asynchronouslopmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc. 541
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electroporated (53 105 cells, 4 mg DNA) using a Microporator MP-100 (Nano-
EnTek Inc, Korea) according to manufacturer’s instructions.
Time Lapse Imaging
Time lapse imaging was performed on cells in L15 medium with 10% serum
using a Deltavision microscope (Applied Precision) equipped with either
a CoolSNAP HQ or a Cascade II EMCCD 512K camera (Photometrics) and
an Olympus 403UApo NA 1.35 objective. A GC400 filter was used to eliminate
UV. FRET imaging was performed using a CFP/YFP filter set: CFPex 436/10,
CFPem 470/30, YFPem 535/30, CFP/YFP dichroic C41258 or a CFP/YFP/
mCherry dichroic C85363 (Chroma Technologies). The bleed-through of the
CFP emission signal in the YFP emission channel was 55% or 100% using
the CFP/YFP and CFP/YFP/mCherry dichroics, respectively. The use of one or
the other dichroic mirror did not affect the behavior of the FRET signal during
mitosis but affected the initial value of the emission ratio (2 for CFP/YFP
dichroic, 3 for CFP/YFP/mCherry dichroic). To facilitate comparison of the
different FRET curves, we expressed the emission ratio as a percentage of
the initial value. The same exposure time was used for CFPex/CFPem and
CFPex/YFPem (between 100 and 200 ms). For the centrosome separation
experiments, 3 z sections 2 mm apart were recorded for each cell and excita-
tion wavelength. All quantifications were performed using ImageJ software.
For emission ratio measurements, we used the following formula:
Whole-Cell Signal = Sum of the Intensity of the Pixels for One Cell
Background signal = average signal per pixel for a region selected just
beside the cell.
Whole-cell signal corrected = whole-cell signal  (number of pixels for the
selected cell = surface selected 3 background).
Emission ratio = whole-cell YFP signal corrected/whole-cell CFP signal
corrected.
Intensity-modulated display (IMD) representations were performed using
Metamorph Software. Briefly, for each IMD, we used 8 color hues with 32
intensities ranking from dark to bright. The max and min values were fixed
manually and are indicated on each figure. The color intensities displayed
for each hue were determined automatically by the software using one of
the CFPex/YFPem images as a reference (see Tsien and Harootunian, 1990).
For photobleaching experiments, cells were illuminated under YFP excita-
tion light (YFPex 500/20; mercury bulb 100W) without neutral density filter
for 5 min. This resulted in a >80% decrease of the YFP emission. The increase
of CFP emission under CFP excitation light was recorded and normalized for
100% bleaching of YFP emission. Using cells expressing YPet alone, we did
not observe any photoconversion of YFP molecules to CFP-like species under
our experimental conditions (Valentin et al, 2005; Thaler et al., 2006).
For reversion to mitosis experiments, we used a FCS2 chamber (Bioptechs).
The volume used was 150 ml and for washout the pump speed was calibrated
in order to have 3 washes per min during 2–3 min.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
devcel.2010.02.013.
ACKNOWLEDGMENTS
We are grateful to Tim Hunt and Jane Kirk for MEF CyclinB2/ cells, Dr. L.
Vassilev and Prof. A. Giannis for RO3306, Nick Keen for ZM447439, Dave
Piston for the Cerulean cDNA, Patrick Daugherty for the YPet cDNA, Cristina
Cardoso for pDsRed1 DNA ligase I cDNA, and Rob Wolthuis for Cdk1AF-
YFP. We thank all members of our laboratory, in particular Takahiro Matsu-
saka, for help in experiments and stimulating discussions. O.G. was supported
by a Marie Curie fellowship and MRC project grants. Work in J.P.’s laboratory
is funded by a program grant from Cancer Research UK.
Received: October 19, 2009
Revised: January 29, 2010
Accepted: February 25, 2010
Published: April 19, 2010542 Developmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier IREFERENCES
Abrieu, A., Brassac, T., Galas, S., Fisher, D., Labbe´, J.C., and Dore´e, M. (1998).
The Polo-like kinase Plx1 is a component of the MPF amplification loop at
the G2/M-phase transition of the cell cycle in Xenopus eggs. J. Cell Sci. 111,
1751–1757.
Blangy, A., Lane, H.A., d’He´rin, P., Harper, M., Kress, M., and Nigg, E.A. (1995).
Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a
kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83,
1159–1169.
Borgne, A., Ostvold, A.C., Flament, S., and Meijer, L. (1999). Intra-M phase-
promoting factor phosphorylation of cyclin B at the prophase/metaphase
transition. J. Biol. Chem. 274, 11977–11986.
Brandeis, M., Rosewell, I., Carrington, M., Crompton, T., Jacobs, M.A., Kirk, J.,
Gannon, J., and Hunt, T. (1998). Cyclin B2-null mice develop normally and are
fertile whereas cyclin B1-null mice die in utero. Proc. Natl. Acad. Sci. USA 95,
4344–4349.
Brito, D.A., and Rieder, C.L. (2006). Mitotic checkpoint slippage in humans
occurs via cyclin B destruction in the presence of an active checkpoint.
Curr. Biol. 16, 1194–1200.
Clute, P., and Pines, J. (1999). Temporal and spatial control of cyclin B1
destruction in metaphase. Nat. Cell Biol. 1, 82–87.
D’Amours, D., and Amon, A. (2004). At the interface between signaling and
executing anaphase—Cdc14 and the FEAR network. Genes Dev. 18, 2581–
2595.
den Elzen, N., and Pines, J. (2001). Cyclin A is destroyed in prometaphase and
can delay chromosome alignment and anaphase. J. Cell Biol. 153, 121–136.
Ditchfield, C., Johnson, V.L., Tighe, A., Ellston, R., Haworth, C., Johnson, T.,
Mortlock, A., Keen, N., and Taylor, S.S. (2003). Aurora B couples chromosome
alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kineto-
chores. J. Cell Biol. 161, 267–280.
Draviam, V.M., Orrechia, S., Lowe, M., Pardi, R., and Pines, J. (2001). The
localization of human cyclins B1 and B2 determines CDK1 substrate
specificity and neither enzyme requires MEK to disassemble the Golgi
apparatus. J. Cell Biol. 152, 945–958.
Easwaran, H.P., Schermelleh, L., Leonhardt, H., and Cardoso, M.C. (2004).
Replication-independent chromatin loading of Dnmt1 during G2 and M
phases. EMBO Rep. 5, 1181–1186.
Elia, A.E., Cantley, L.C., and Yaffe, M.B. (2003). Proteomic screen finds
pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science
299, 1228–1231.
Fu, Z., Malureanu, L., Huang, J., Wang, W., Li, H., van Deursen, J.M., Tindall,
D.J., and Chen, J. (2008). Plk1-dependent phosphorylation of FoxM1 regu-
lates a transcriptional programme required for mitotic progression. Nat. Cell
Biol. 10, 1076–1082.
Gautier, J., Minshull, J., Lohka, M., Glotzer, M., Hunt, T., and Maller, J.L.
(1990). Cyclin is a component of MPF from Xenopus. Cell 60, 487–494.
Gavet, O., and Pines, J. (2010). Activation of cyclin B1-Cdk1 synchronizes
events in the nucleus and the cytoplasm at mitosis. J. Cell Biol. 189, 247–259.
Geley, S., Kramer, E., Gieffers, C., Gannon, J., Peters, J.-M., and Hunt, T.
(2001). APC/C-dependent proteolysis of human cyclin A starts at the beginning
of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol.
153, 137–148.
Gong, D., Pomerening, J.R., Myers, J.W., Gustavsson, C., Jones, J.T., Hahn,
A.T., Meyer, T., and Ferrell, J.E., Jr. (2007). Cyclin A2 regulates nuclear-envelope
breakdown and the nuclear accumulation of cyclin B1. Curr. Biol. 17, 85–91.
Hagting, A., Jackman, M., Simpson, K., and Pines, J. (1999). Translocation of
cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent
nuclear import signal. Curr. Biol. 9, 680–689.
Hagting, A., Den Elzen, N., Vodermaier, H.C., Waizenegger, I.C., Peters, J.M.,
and Pines, J. (2002). Human securin proteolysis is controlled by the spindle
checkpoint and reveals when the APC/C switches from activation by Cdc20
to Cdh1. J. Cell Biol. 157, 1125–1137.nc.
Developmental Cell
CyclinB1-Cdk1 Coordinates Entry to MitosisHoffmann, I., Clarke, P.R., Marcote, M.J., Karsenti, E., and Draetta, G. (1993).
Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its
involvement in the self-amplification of MPF at mitosis. EMBO J. 12, 53–63.
Holmes, J.K., and Solomon, M.J. (1996). A predictive scale for evaluating
cyclin-dependent kinase substrates. A comparison of p34cdc2 and
p33cdk2. J. Biol. Chem. 271, 25240–25246.
Izumi, T., and Maller, J.L. (1993). Elimination of cdc2 phosphorylation sites in the
cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell 4, 1337–1350.
Jackman, M., Lindon, C., Nigg, E.A., and Pines, J. (2003). Active cyclin
B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5, 143–148.
Katsuno, Y., Suzuki, A., Sugimura, K., Okumura, K., Zineldeen, D.H., Shimada,
M., Niida, H., Mizuno, T., Hanaoka, F., and Nakanishi, M. (2009). Cyclin A-Cdk1
regulates the origin firing program in mammalian cells. Proc. Natl. Acad. Sci.
USA 106, 3184–3189.
Kim, S.Y., and Ferrell, J.E., Jr. (2007). Substrate competition as a source of
ultrasensitivity in the inactivation of Wee1. Cell 128, 1133–1145.
Knoblich, J.A., and Lehner, C.F. (1993). Synergistic action of Drosophila
cyclins A and B during the G2-M transition. EMBO J. 12, 65–74.
Koop, L. (2007). The role of Cyclin A in the entry to mitosis. PhD thesis, Univer-
sity of Cambridge, Cambridge, United Kingdom.
Kraft, C., Herzog, F., Gieffers, C., Mechtler, K., Hagting, A., Pines, J., and
Peters, J.M. (2003). Mitotic regulation of the human anaphase-promoting
complex by phosphorylation. EMBO J. 22, 6598–6609.
Kwon, Y.G., Lee, S.Y., Choi, Y., Greengard, P., and Nairn, A.C. (1997). Cell
cycle-dependent phosphorylation of mammalian protein phosphatase 1 by
cdc2 kinase. Proc. Natl. Acad. Sci. USA 94, 2168–2173.
Labbe´, J.C., Picard, A., Peaucellier, G., Cavadore, J.C., Nurse, P., and Doree,
M. (1989). Purification of MPF from starfish: identification as the H1 histone
kinase p34cdc2 and a possible mechanism for its periodic activation. Cell
57, 253–263.
Le´na´rt, P., Petronczki, M., Steegmaier, M., Di Fiore, B., Lipp, J.J., Hoffmann,
M., Rettig, W.J., Kraut, N., and Peters, J.M. (2007). The small-molecule
inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase
1. Curr. Biol. 17, 304–315.
Lindqvist, A., van Zon, W., Karlsson Rosenthal, C., and Wolthuis, R.M. (2007).
Cyclin B1-Cdk1 activation continues after centrosome separation to control
mitotic progression. PLoS Biol. 5, e123. 10.1371/journal.pbio.0050123.
Lindqvist, A., Rodriguez-Bravo, V., and Medema, R.H. (2009). The decision to
enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell
Biol. 185, 193–202.
Lobjois, V., Jullien, D., Bouche´, J.P., and Ducommun, B. (2009). The polo-like
kinase 1 regulates CDC25B-dependent mitosis entry. Biochim. Biophys. Acta
1793, 462–468.
Lohka, M.J., Hayes, M.K., and Maller, J.L. (1988). Purification of maturation-
promoting factor, an intracellular regulator of early mitotic events. Proc. Natl.
Acad. Sci. USA 85, 3009–3013.
Matsusaka, T., and Pines, J. (2004). Chfr acts with the p38 stress kinases to
block entry to mitosis in mammalian cells. J. Cell Biol. 166, 507–516.
Meraldi, P., and Nigg, E.A. (2001). Centrosome cohesion is regulated by
a balance of kinase and phosphatase activities. J. Cell Sci. 114, 3749–3757.
Mochida, S., and Hunt, T. (2007). Calcineurin is required to release Xenopus
egg extracts from meiotic M phase. Nature 449, 336–340.
Morgan, D.O. (2007). The Cell Cycle: Principles of Control (Oxford: Oxford
University Press).
Nguyen, A.W., and Daugherty, P.S. (2005). Evolutionary optimization of
fluorescent proteins for intracellular FRET. Nat. Biotechnol. 23, 355–360.
Nigg, E.A. (1993). Cellular substrates of p34(cdc2) and its companion cyclin-
dependent kinases. Trends Cell Biol. 3, 296–301.
Ohkura, H., Kinoshita, N., Miyatani, S., Toda, T., and Yanagida, M. (1989). The
fission yeast dis2+ gene required for chromosome disjoining encodes one of
two putative type 1 protein phosphatases. Cell 57, 997–1007.
Pines, J., and Hunter, T. (1990). Human cyclin A is adenovirus E1A-associated
protein p60 and behaves differently from cyclin B. Nature 346, 760–763.DevePines, J., andHunter, T. (1991). Human cyclins A andB1 are differentially located in
the cell andundergo cell cycle-dependent nuclear transport. J. CellBiol.115, 1–17.
Pines, J., and Rieder, C.L. (2001). Re-staging mitosis: a contemporary view of
mitotic progression. Nat. Cell Biol. 3, E3–E6.
Pomerening, J.R., Sontag, E.R., and Ferrell, J.E., Jr. (2003). Building a cell
cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell
Biol. 5, 346–351.
Pomerening, J.R., Ubersax, J.A., and Ferrell, J.E., Jr. (2008). Rapid cycling and
precocious termination of G1 phase in cells expressing CDK1AF. Mol. Biol.
Cell 19, 3426–3441.
Potapova, T.A., Daum, J.R., Pittman, B.D., Hudson, J.R., Jones, T.N.,
Satinover, D.L., Stukenberg, P.T., and Gorbsky, G.J. (2006). The reversibility
of mitotic exit in vertebrate cells. Nature 440, 954–958.
Rieder, C.L., and Cole, R.W. (1998). Entry into mitosis in vertebrate somatic cells
is guarded by a chromosome damage checkpoint that reverses the cell cycle
when triggered during early but not late prophase. J. Cell Biol. 142, 1013–1022.
Rizzo, M.A., Springer, G.H., Granada, B., and Piston, D.W. (2004). An
improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol.
22, 445–449.
Rudner, A.D., and Murray, A.W. (2000). Phosphorylation by Cdc28 activates
the Cdc20-dependent activity of the anaphase-promoting complex. J. Cell
Biol. 149, 1377–1390.
Sawin, K.E., and Mitchison, T.J. (1995). Mutations in the kinesin-like protein
Eg5 disrupting localization to the mitotic spindle. Proc. Natl. Acad. Sci. USA
92, 4289–4293.
Seong, Y.S., Kamijo, K., Lee, J.S., Fernandez, E., Kuriyama, R., Miki, T., and
Lee, K.S. (2002). A spindle checkpoint arrest and a cytokinesis failure by the
dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem.
277, 32282–32293.
Sha, W., Moore, J., Chen, K., Lassaletta, A.D., Yi, C.S., Tyson, J.J., and Sible,
J.C. (2003). Hysteresis drives cell-cycle transitions in Xenopus laevis egg
extracts. Proc. Natl. Acad. Sci. USA 100, 975–980.
Soni, D.V., Sramkoski, R.M., Lam, M., Stefan, T., and Jacobberger, J.W.
(2008). CyclinB1 is rate limiting but not essential for mitotic entry and progres-
sion in mammalian somatic cells. Cell Cycle 7, 1285–1300.
Stern, B., and Nurse, P. (1996). A quantitative model for the cdc2 control of S
phase and mitosis in fission yeast. Trends Genet. 12, 345–350.
Thaler, C., Vogel, S.S., Ikeda, S.R., and Chen, H. (2006). Photobleaching of
YFP does not produce a CFP-like species that affects FRET measurements.
Nat. Methods 3, 491.
Tsien, R.Y., and Harootunian, A.T. (1990). Practical design criteria for
a dynamic ratio imaging system. Cell Calcium 11, 93–109.
Valentin, G., Verheggen, C., Piolot, T., Neel, H., Coppey-Moisan, M., and Ber-
trand, E. (2005). Photoconversion of YFP into a CFP-like species during
acceptor photobleaching FRET experiments. Nat. Methods 2, 801.
Vigneron, S., Brioudes, E., Burgess, A., Labbe´, J.C., Lorca, T., and Castro, A.
(2009). Greatwall maintains mitosis through regulation of PP2A. EMBO J. 28,
2786–2793.
Watanabe, N., Broome, M., and Hunter, T. (1995). Regulation of the human
Wee1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J.14, 1878–1891.
Wu, J.Q., Guo, J.Y., Tang, W., Yang, C.-S., Freel, C.D., Chen, C., Nairn, A.C.,
and Kornbluth, S. (2009). PP1-mediated dephosphorylation of phosphopro-
teins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation.
Nat. Cell Biol. 11, 644–651.
Yamano, H., Ishii, K., and Yanagida, M. (1994). Phosphorylation of dis2 protein
phosphatase at the C-terminal cdc2 consensus and its potential role in cell
cycle regulation. EMBO J. 13, 5310–5318.
Zhang, J., Ma, Y., Taylor, S.S., and Tsien, R.Y. (2001). Genetically encoded
reporters of protein kinase A activity reveal impact of substrate tethering.
Proc. Natl. Acad. Sci. USA 98, 14997–15002.
Zhao, Y., Haccard, O., Wang, R., Yu, J., Kuang, J., Jessus, C., and Goldberg,
M.L. (2008). Roles of Greatwall kinase in the regulation of cdc25 phosphatase.
Mol. Biol. Cell 19, 1317–1327.lopmental Cell 18, 533–543, April 20, 2010 ª2010 Elsevier Inc. 543
